Scleral Lenses Market

By Product Type;

Corneo-Scleral Lenses & Semi-Scleral Lenses, Mini-Scleral Lenses, and Full Scleral Lenses

By Application;

Irregular Cornea, Ocular Surface Disease, Refractive Error, GP Burnout, Astigmatism, Dry Eye, and Others

By End User;

Hospitals, Eye Clinics, and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn133809862 Published Date: June, 2025 Updated Date: August, 2025

Scleral Lenses Market Overview

Scleral Lenses Market (USD Million)

Scleral Lenses Market was valued at USD 389.37 million in the year 2024. The size of this market is expected to increase to USD 1,153.31 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 16.8%.


Scleral Lenses Market

*Market size in USD million

CAGR 16.8 %


Study Period2025 - 2031
Base Year2024
CAGR (%)16.8 %
Market Size (2024)USD 389.37 Million
Market Size (2031)USD 1,153.31 Million
Market ConcentrationLow
Report Pages311
389.37
2024
1,153.31
2031

Major Players

  • Bausch Health Companies Inc.
  • CooperVision Inc.
  • Essilor International S.A.
  • Menicon Co., Ltd.
  • Novartis International AG
  • Johnson & Johnson Vision Care, Inc.
  • SynergEyes, Inc.
  • Blanchard Contact Lenses
  • Art Optical Contact Lens, Inc.
  • Kontur Kontact Lens Company

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Scleral Lenses Market

Fragmented - Highly competitive market without dominant players


The Scleral Lenses Market is witnessing steady growth driven by increasing awareness and the rising adoption of scleral lenses among patients with 20% to 30% of contact lens users transitioning due to their enhanced comfort and vision correction capabilities. The market expansion is supported by advancements in material science and improved lens designs, fostering greater patient acceptance and satisfaction.

Technological Advancements and Innovation
Innovation plays a critical role in the market, with nearly 40% of newly launched products featuring advanced gas-permeable materials and customized fittings. These technological advancements enhance oxygen permeability and wearer comfort, significantly improving treatment outcomes. Continuous research and development efforts foster breakthroughs in lens durability and ease of application, driving market growth.

Strategic Collaborations and Partnerships
The market benefits from strategic collaborations, mergers, and partnerships, accounting for roughly 33% of recent activities aimed at product development and distribution. These partnerships enable resource pooling and expertise sharing, accelerating the commercialization of innovative scleral lens solutions. Collaborative efforts between manufacturers and eye care providers are expanding product accessibility and market reach.

Future Outlook and Emerging Trends
The future outlook for the market is promising, with more than 45% of industry initiatives focusing on personalized lenses and digital fitting technologies. The integration of advanced imaging and patient-centric design approaches highlights ongoing commitment to enhanced vision correction. Sustained innovation and strategic expansion efforts are expected to drive continuous market growth and improved patient outcomes.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By Application
    3. Market Snapshot, By End User
    4. Market Snapshot, By Region
  4. Scleral Lenses Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Vision Correction Innovation
        2. Rising Eye Disorders
        3. Technological Advancements
        4. Aging Population
        5. Growing Awareness
      2. Restraints
        1. Costly Manufacturing
        2. Limited Accessibility
        3. Regulatory Hurdles
        4. Lack of Awareness
        5. Complex Fitting Process
      3. Opportunities
        1. Emerging Markets Expansion
        2. Customization Options Growth
        3. Telemedicine Integration
        4. Enhanced Comfort Solutions
        5. Collaborative Research Initiatives
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Scleral Lenses Market,By Product Type, 2021 - 2031 (USD Million)
      1. Corneo-Scleral Lenses & Semi-Scleral Lenses
      2. Mini-Scleral Lenses
      3. Full Scleral Lenses
    2. Scleral Lenses Market, By Application, 2021 - 2031 (USD Million)
      1. Irregular Cornea
      2. Ocular Surface Disease
      3. Refractive Error
      4. GP Burnout
      5. Astigmatism
      6. Dry Eye
      7. Others
    3. Scleral Lenses Market, By End User, 2021 - 2031 (USD Million)

      1. Hospitals

      2. Eye Clinics

      3. Others

    4. Scleral Lenses Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Bausch Health Companies Inc.
      2. CooperVision Inc.
      3. Essilor International S.A.
      4. Menicon Co., Ltd.
      5. Novartis International AG
      6. Johnson & Johnson Vision Care, Inc.
      7. SynergEyes, Inc.
      8. Blanchard Contact Lenses
      9. Art Optical Contact Lens, Inc.
      10. Kontur Kontact Lens Company
  7. Analyst Views
  8. Future Outlook of the Market